Document Detail

Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy.
MedLine Citation:
PMID:  17541123     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Left ventricular outflow tract (LVOT) obstruction in the setting of hypertrophic cardiomyopathy (HCM) confers negative adverse outcomes. Current nonpharmacologic treatment options include surgical myectomy and percutaneous transcoronary ablation of septal hypertrophy (TASH). While TASH negates a more invasive procedure, concern remains with particular regard to the arrhythmogenic potential of the resultant myocardial scar. Percutaneous transvalvular endomyocardial septal cryoablation (PTESC) may circumvent some of these potential limitations and offer a novel treatment strategy. OBJECTIVES: The purpose of this study was to report our early experience and outcomes with percutaneous endomyocardial cryoablation of the interventricular septum in obstructive HCM. METHODS AND RESULTS: Between March 2005 and May 2006, 3 patients (2 male, 1 female) with symptomatic obstructive HCM underwent PTESC. Basal LVOT gradients measured during left heart catheterization were 70, 126 and 100 mmHg for Patients 1, 2 and 3, respectively. Using 7 Fr and 9 Fr 8 mm tip CryoCath Freezor catheters (CryoCath Technologies, Inc., Montreal, Quebec, Canada), cryothermal energy was applied to the interventricular septum under fluoroscopic guidance. A total of 20 to 32 applications of cryothermal energy were delivered, with the mean nadir temperature sustained during cryoablation being -88 degrees Celcius. Two of the 3 patients had an immediate reduction in the LVOT gradient. However, at 6 months, only 1 patient had a significant sustained reduction in LVOT gradient. No adverse events relating to the procedure were experienced. CONCLUSION: PTESC is feasible, but did not result in a significant, sustained reduction in LVOT gradient in 2 of the 3 patients in this small series of obstructive HCM patients. The technique warrants further study to improve the consistency and duration of reduction in outflow gradient.
David Keane; Brian Hynes; Gerard King; Paul Shiels; Angie Brown
Related Documents :
8198033 - Comparison of defibrillator therapy and other therapeutic modalities for sustained vent...
3825943 - Evaluation of pacemaker pulse generator and patient longevity in patients aged 1 day to...
17338763 - Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  19     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-06-01     Completed Date:  2007-08-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  247-51     Citation Subset:  IM    
Department of Cardiac Arrhythmia, St. Vincent's University Hospital, Dublin, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomyopathy, Hypertrophic / physiopathology,  surgery*
Cryosurgery / methods*
Defibrillators, Implantable
Feasibility Studies
Heart Catheterization
Heart Septum / surgery
Middle Aged
Ventricular Function, Left
Comment In:
J Invasive Cardiol. 2007 Aug;19(8):357   [PMID:  17712207 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of nonuniform strut distribution between two drug-eluting stent platforms.
Next Document:  Analysis of left and right ventricular Doppler tissue imaging in patients undergoing percutaneous cl...